Psychotropic Meds for Foster Kids Controversial
Over the past decade, use of psychotropic medications for youth has more than doubled.
Moreover, for foster children, the rates are much higher, with an astonishing 13 to 52 percent of foster kids receiving the medications, as compared to 4 percent of the general youth population.
In response, a newly released multi-state report from The Tufts Clinical and Translational Science Institute (CTSI), examines state policies and practices regarding the use of medication for treating behavioral and mental health problems in foster care children and adolescents ages 2 to 21 years.
In 2008, President Bush signed into law the Fostering Connections to Success and Increasing Adoptions Act, which requires state child welfare agencies and Medicaid to provide ongoing oversight and coordination of medical and mental health services, including psychotropic medications, for youth in foster care.
Since then, state child welfare agencies have been working to develop sound policies and practices for this population of kids.
The Tufts CTSI multi-state study, begun in 2009, concluded that while oversight of psychotropic medication is a high priority of the state child welfare agencies, there is also great variability among the state policies and practices governing such oversight.
The study calls for a national approach and resources for medication oversight for youth in foster care. A more detailed national look at which state policies and practices are the most effective for improving the mental health of these youth is also needed.
Without a national approach, crossing a state border could mean the difference between a youth in foster care being appropriately treated with medications or not.
The report also stresses the need for youth-serving organizations and state agencies to work together, and for more informed decision-making and appropriate medication monitoring for youth in foster care.
The majority of states in the multi-state study reported an increasing trend in the use of psychotropic medications among youth in foster care, specifically regarding: increased use of antipsychotics, antidepressants, and attention-deficit hyperactivity disorder (ADHD) medications; increased polypharmacy (the use of more than one psychotropic medication at the same time); increased medication use among young children; and increased reliance on giving medications “as needed” and “blanket authorizations” for such drug use in residential facilities.
Officials in some states felt that this increase partially reflected demand by foster parents, schools, and other stakeholders.
Others felt that reimbursement and time pressures in the health care system encouraged medication use. A few states, however, indicated a decrease in medication use in their states and thought that these changes reflected policy and practices implemented over the last several years.
Many child welfare officials understood that medication plays an important role in addressing mental health problems. However, officials were concerned that medications were being used to manage problems that might respond as well, or better, to psychosocial treatments.
The study involved interviews with state child welfare agency key staff as well as a review of existing policies and guidelines available on state public websites or provided by staff.
The new report was funded by the Charles H. Hood Foundation and the National Institute of Mental Health-funded Child and Adolescent Services Research Center in San Diego.
Nauert PhD, R. (2018). Psychotropic Meds for Foster Kids Controversial. Psych Central. Retrieved on July 11, 2020, from https://psychcentral.com/news/2010/09/24/psychotropic-meds-for-foster-kids-controversial/18674.html